Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

355 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biological and clinical associations of c-jun activation in human breast cancer.
Gee JM, Barroso AF, Ellis IO, Robertson JF, Nicholson RI. Gee JM, et al. Among authors: robertson jf. Int J Cancer. 2000 Mar 20;89(2):177-86. doi: 10.1002/(sici)1097-0215(20000320)89:2<177::aid-ijc13>3.0.co;2-0. Int J Cancer. 2000. PMID: 10754497
Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.
Robertson JF, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW. Robertson JF, et al. Breast Cancer Res Treat. 1992;22(3):221-7. doi: 10.1007/BF01840835. Breast Cancer Res Treat. 1992. PMID: 1391988
Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment.
Low SC, Dixon AR, Bell J, Ellis IO, Elston CW, Robertson JF, Blamey RW. Low SC, et al. Among authors: robertson jf. Br J Surg. 1992 Dec;79(12):1314-6. doi: 10.1002/bjs.1800791224. Br J Surg. 1992. PMID: 1486427 Clinical Trial.
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Robertson JF, Bates K, Pearson D, Blamey RW, Nicholson RI. Robertson JF, et al. Br J Cancer. 1992 May;65(5):727-30. doi: 10.1038/bjc.1992.153. Br J Cancer. 1992. PMID: 1534019 Free PMC article.
Cellular effects of tamoxifen in primary breast cancer.
Robertson JF, Ellis IO, Nicholson RI, Robins A, Bell J, Blamey RW. Robertson JF, et al. Breast Cancer Res Treat. 1992 Jan;20(2):117-23. doi: 10.1007/BF01834641. Breast Cancer Res Treat. 1992. PMID: 1554887
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP, Robertson JF, Ellis IO, Nicholson RI, Crocker J, Blamey RW. Sacks NP, et al. Among authors: robertson jf. Eur J Surg Oncol. 1992 Apr;18(2):98-102. Eur J Surg Oncol. 1992. PMID: 1582518
An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JF, Blamey RW. du Toit RS, et al. Among authors: robertson jf. Eur J Surg Oncol. 1991 Jun;17(3):251-7. Eur J Surg Oncol. 1991. PMID: 1646127 Clinical Trial.
c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW. Lovekin C, et al. Among authors: robertson jf. Br J Cancer. 1991 Mar;63(3):439-43. doi: 10.1038/bjc.1991.101. Br J Cancer. 1991. PMID: 1672254 Free PMC article.
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation.
Nicholson RI, Bouzubar N, Walker KJ, McClelland R, Dixon AR, Robertson JF, Ellis IO, Blamey RW. Nicholson RI, et al. Among authors: robertson jf. Eur J Cancer. 1991;27(7):908-13. doi: 10.1016/0277-5379(91)90145-4. Eur J Cancer. 1991. PMID: 1834127
Prospective assessment of the role of five tumour markers in breast cancer.
Robertson JF, Pearson D, Price MR, Selby C, Pearson J, Blamey RW, Howell A. Robertson JF, et al. Cancer Immunol Immunother. 1991;33(6):403-10. doi: 10.1007/BF01741602. Cancer Immunol Immunother. 1991. PMID: 1878893
355 results
Jump to page
Feedback